Financial Perspectives, Inc
Position in SUPN — Supernus Pharmaceuticals, Inc.
CIK 2003287
MINNEAPOLIS, MN
Position in SUPN
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$2,418
-$269 QoQ
Shares Held
52
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#292
of 331 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in SUPN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Financial Perspectives, Inc holds $444,323 across 8 Drug Manufacturers - Specialty & Generic names. SUPN ranks #6 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
11,251 | $381,183 | |
| 2 | TAK |
Takeda Pharmaceutical Co Ltd
|
1,437 | $23,035 | |
| 3 | VTRS |
Viatris Inc
|
1,366 | $21,692 | |
| 4 | ZTS |
Zoetis Inc.
|
139 | $9,988 | |
| 5 | HLN |
Haleon plc
|
628 | $5,859 | |
| 6 | SUPN |
Supernus Pharmaceuticals, Inc.
This page
|
52 | $2,418 | |
| 7 | CRON |
Cronos Group Inc.
|
45 | $125 | |
| 8 | OGI |
Organigram Global Inc.
|
23 | $23 |
All Filings in SUPN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,418 | 52 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $2,687 | 52 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $2,584 | 52 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $2,485 | 52 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $1,639 | 52 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $1,703 | 52 | Shares | Sole | 2025-04-18 | |
| 2024-12-31 | $1,880 | 52 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $1,621 | 52 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $1,391 | 52 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $1,773 | 52 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $1,504 | 52 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $1,433 | 52 | Shares | Sole | 2024-01-10 | |
| 2023-06-30 | $1,563 | 52 | Shares | Sole | 2024-01-10 | |
| 2023-03-31 | $1,883 | 52 | Shares | Sole | 2024-01-10 | |
| 2022-12-31 | $1,854 | 52 | Shares | Sole | 2024-01-10 | |
| 2022-09-30 | $1,760 | 52 | Shares | Sole | 2024-01-10 | |
| 2022-06-30 | $1,503 | 52 | Shares | Sole | 2024-01-10 | |
| 2022-03-31 | $1,680 | 52 | Shares | Sole | 2024-01-10 | |
| 2021-12-31 | $1,516 | 52 | Shares | Sole | 2024-01-10 | |
| 2021-09-30 | $1,386 | 52 | Shares | Sole | 2024-01-10 | |
| 2021-06-30 | $1,601 | 52 | Shares | Sole | 2024-01-10 | |
| 2021-03-31 | $52 | 1,361 | Shares | Sole | 2024-01-10 | |
| 2020-12-31 | $1,308 | 52 | Shares | Sole | 2024-01-10 | |
| 2020-09-30 | $1,083 | 52 | Shares | Sole | 2024-01-10 | |
| 2020-06-30 | $1,235 | 52 | Shares | Sole | 2024-01-10 | |
| 2020-03-31 | $935 | 52 | Shares | Sole | 2024-01-10 | |
| No filing history on record for this holder in this stock. | ||||||